Publications

The Pandemic Recovery Metrics to Drive Equity – PanREMEDY project sought to give form to the least considered phase of a catastrophic outbreak of infectious disease, while applying an equity lens. The project inquired, “By what measures could local and state decision makers know that efforts at holistic recovery were working, especially for the socially vulnerable individuals and communities hit hardest by COVID-19?”

Great benefits to humanity will likely ensue from advances in artificial intelligence (AI) models trained on or capable of meaningfully manipulating substantial quantities of biological data, from speeding up drug and vaccine design to improving crop yields.^1-3 But as with any powerful new technology, such biological models will also pose considerable risks.

A rapidly growing mpox outbreak is heightening concern over a potential multicountry epidemic or even a new pandemic. This year alone, there have been more than 17 000 suspected (2863 confirmed) cases of mpox across the African continent, with the majority in the Democratic Republic of the Congo (DRC).

In the United States, state, tribal, local, and territorial public health agencies play a vital role in responding to infectious disease outbreaks. One foundational strategy for controlling communicable diseases is case investigation/contact tracing (CI/CT), an approach that has been routinely employed in the United States and global settings to control sexually transmitted infections, tuberculosis, and outbreaks of emerging infections such as Ebola and COVID-19.¹ When effectively implemented at the early stages of an outbreak, CI/CT programs promptly identify cases and their contacts and apply prevention and control measures, thereby preventing onward transmission of disease in communities.¹

The 2024 meeting of the Southeast Asia Strategic Multilateral Biosecurity Dialogue was held in Singapore, with participants from Indonesia, Malaysia, the Philippines, Singapore, Thailand, and the United States. The dialogue is conducted at the Track 1.5 level, with current and former government officials—participating in their personal capacity—and civil society experts collaborating to identify priority threats and gaps, share experiences and lessons, and propose opportunities to strengthen national and regional resilience against natural, accidental, and deliberate biological threats. 

The Johns Hopkins Center for Health Security convened an in-person, not-for-attribution stakeholder discussion on April 25, 2024, to: 1) examine how reusable respirators (RRs) used at scale would protect against supply chain shocks in large emergencies, cost less per respirator than single-use disposable respirators over the life of the product, and provide better protection for workers; and 2) inform a national strategy to promote stockpiling of RRs by the US government, encourage greater adoption of RRs by the healthcare sector, incentivize innovation in RR design, and create a stronger demand signal for industry.

Mass gatherings include a diverse range of events such as sporting competitions, religious ceremonies, entertainment activities, political rallies and cultural celebrations, which have important implications for population well-being. However, if not managed properly, these events can amplify health risks including those related to communicable diseases, and place undue strain on health systems in host countries and potentially in attendees’ home countries, upon their return.

This checklist is an instrument to help public health departments and communicators improve trust and communication, especially in anticipation of serious public health issues, health emergencies, and when misinformation is abundant.

Artificial intelligence (AI) tools continue to be developed and used within the life sciences. The impact of these tools on the biosecurity landscape surrounding mail-order DNA synthesis and how to address the impacts have not been critically examined in the literature.

The Pneumoviridae viral family, formerly a subfamily of Paramyxoviridae, consists of 2 genera: Orthopneumovirus, the members of which infect mammals, and Metapneumovirus, which are specific for either mammals or birds.

Evidence suggests that reductions in healthcare utilization, including forgone care, during the COVID-19 pandemic may be contributing towards excess morbidity and mortality. The objective of this study was to describe individual and community-level correlates of forgone care during the COVID-19 pandemic.

2024 is the year of international climate change litigation, with accountability for the protection of health elevated to global and regional courts and tribunals. On April 9, 2024, the European Court of Human Rights concluded that Switzerland violated the rights of a group of older Swiss women, known as the KlimaSeniorinnen Schweiz, who had brought the case against Switzerland for failing to meet its past greenhouse gas (GHG) emissions reduction targets and set future GHG targets.

At the end of May, 194 member states of the World Health Organization (WHO) will meet for the World Health Assembly. Negotiations underway now will determine whether they vote then to adopt a pandemic agreement. For the past 2 years, discussions have focused on articulating essential components of a robust and equitable architecture for pandemic preparedness and response. Despite this, talks have failed to produce sufficient consensus on a detailed draft, prompting the intergovernmental negotiating body to propose a “streamlined” version.

Bioindustrial manufacturing is undergoing rapid expansion and investment and is seen as integral to nations’ economic progress. Ensuring that bioindustrial manufacturing benefits society as the field expands is of critical, urgent importance. To better understand the industry’s ethical trajectory and to shape policy, we explored the views of biotechnology leaders on four aspects of ethical and social responsibility—safety, security, social responsibility, and sustainability—what we have termed “4S principles.” We identified policy actions governments and other stakeholders may take to maximize societal benefits in industrial biotechnology.

In this case study, we describe a well-resourced private school in New York City that implemented COVID-19mitigation measures based on public health expert guidance and the lessons learned from this process